Exploration-Hypothesis Development Award – HT942526NFRPEHDA
- Letters of Intent due 8 September 2026
- Up to USD$160,000 over 2 years
- Supports the initial exploration of innovative, high-risk, high-gain and potentially groundbreaking concepts
- studies should lay the groundwork for future avenues of scientific investigation
- Preliminary and/or published data encouraged but not required.
- Clinical trials not allowed.
- must address one or more of the areas of emphasis
- Apply here
- Document – Program Announcement – HT042526NFRPEHDA_GG
Investigator-Initiated Research Award – HT942526NFRPIIRA
- Letters of Intent due 8 September 2026
- Up to USD$840,000 over 3 years (Funding Level 1)
- Additional USD$80,000 available for proposals including either the Qualified Collaborator or NF Open Science Initiative options (Funding Level 2)
- Investigators at or above the level of Associate Professor or equivalent
- Supports highly rigorous, high-impact research projects that have the potential to make an important contribution to NF research and/or patient care.
- Preliminary and/or published data required
- clinical trials not allowed
- must address one or more of the areas of emphasis
- Apply here
- Document – Program Announcement – HT042526NFRPIIRA_GG
Synergistic Idea Award – HT942526NFRPSIA
- Letters of Intent due 8 September 2026
- Up to USD$3.2M over 3 years
- Investigators at or above the level of Assistant Professor or equivalent
- Supports new ideas that represent synergistic approaches involving two or three PIs
- Applications must demonstrate the synergistic components (ie leveraging disciplines, expertise, or critical resources) that will significantly advance the project and enable rapid and efficient realization of research outcomes impossible to accomplish through the independent efforts of a single investigator
- Preliminary and/or published data required
- clinical trials not allowed
- must address one or more of the areas of emphasis
- Apply here
- Document – Program Announcement – HT942526NFRPSIA_GG
Neurofibromatosis Research Academy (NFRA) – Scholar Award – HT942526NFRPNFRASA
- Letters of Intent due 8 September 2026
- up to USD$1.2M over 4 years
- Supports ECRs joining the NFRA to pursue a research project that may include basic, translational and/or clinical research under NFRA leadership
- Scholars must be less than 10 years of completion of their terminal degree
- requires a career guide – an independent, established NF investigator with a record of NF publications in peer-reviewed journals
- Preliminary and/or published data encouraged but not required
- clinical trials not allowed
- must address one or more of the areas of emphasis
- Apply here
- Document – Program Announcement – HT942526NFRPNFRASA_GG
Areas of Emphasis
- NF2 and non-NF2 schwannomatosis-related areas, eg hearing, balance, schwannoma, ependymoma, meningioma, LZTR1, SMARCB1
- Endpoint validation, biomarker discovery and technological innovation for assessments
- Application of data science
- Non-tumor manifestations not limited to: Pain; Cognitive manifestations; Sleep
- Heterogeneity of NF-related phenotypes
- Genetics, genomics, epigenetics, systems biology, metabolomics or similar approaches
- Preclinical efficacy studies
- Target identification and drug discovery
- Nutritional, environmental and other modifiers of NF
- Health services research
